SoftServ's capabilities include full stack software development; security, accessibility and disaster recovery audits; mobile app development; containerization; Scientist.com marketplace configurations; and more.
SoftServ was created by Scientist.com's acquisition of Notch8 in Dec 2021. That same year, Scientist.com purchased HealthEconomics.Com, the world's largest Connected Community for the Value, Evidence and Market Access industry; InsideScientific, an online marketing content creator for the life sciences; and BioPharmCatalyst, a research-based portal that provides key catalyst updates for publicly traded biotech companies.
Scientist.com operates online marketplaces for most of the world's top 30 pharmaceutical companies, 120+ biotech companies and the US National Institutes of Health. The award-winning digital research platform helps life scientists test more ideas in less time.
Scientist.com's mission is to empower and connect scientists worldwide.
The company's digital research platform combines a custom-built, cloud native technology stack with white-glove customer and scientific support to enable scientists to run more innovative experiments in less time and at lower cost.
Scientist.com leverages internally developed machine learning models to provide actionable insights that improve operational efficiency and effective research management.
Scientist.com connects researchers at the world's top pharmaceutical companies, biotechnology companies, and the US National Institutes of Health to the world's largest network of scientific research suppliers.
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA